principal investigator



Dr Ninib Baryawno received his PhD diploma at Karolinska Institutet under the supervision of associate professor John Inge Johnsen and professor Per Kogner. His thesis work focused on developing novel therapeutics based on better biological understanding of the childhood brain tumor medulloblastoma. A disorder of development, arising mostly in the cerebellum during embryogenesis and is largely dictated by events in stem cell regulatory signaling pathways. His research was published as a thesis “New Potential Targets in Medulloblastoma Therapy – Studies on Cellular Mechanisms and Mediators”, and defended in February 2010.

It was the interest in stem cell based approaches to disease that brought Dr Baryawno together with professor David Scadden at Harvard University and Massachusetts General Hospital in 2011. Dr Baryawno was a postdoctoral fellow in the Scadden lab until 2017 where he applied single-cell RNA-sequencing to study how the hematopoietic stem cell niche supports outgrowth of murine leukemia and human bone metastases.

Dr Baryawno became Assistant professor at Karolinska Institutet in January 2018. He was promoted to Associate Professor in 2023.


Contact information:

Ninib Baryawno (PhD)

Associate Professor

  • Wideströmska, Tomtebodavägen 18A, 5th floor, 171 65 Solna